BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa
Titel:
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa
Auteur:
Katongole, Fredrick Arumugam, Tiyara Jennings, Angus Mutata, Constantine Ssebunya, Patrick Wamboi, Charity Green, Alexandra Bwakura-Dangarembizi, Mutsa Kityo, Cissy Siika, Abraham Archary, Moherndran Jafta, Lungile Namukwaya, Stella Seeley, Janet Mugerwa, Henry Walker, Simon Apoto, Naomi Thomason, Margaret J. Ford, Deborah Pett, Sarah L. Kekitiinwa, Adeodata R.